AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ARTRYA LTD

1.125

+0.10510.29%

Volume:529.35K

Turnover:580.22K

Market Cap:127.92M

PE:-6.19

High:1.175

Open:1.030

Low:1.015

Close:1.020

Loading ...

Overview Company News Filings

Application for quotation of securities - AYA-AYA.AX

BUZZ-Australia's Artrya rises to highest since January on US hospital group contract

Artrya Signs $600,000 SaaS Deal With US Non-Profit Healthcare Provider

MT Newswires Live

Notification of cessation of securities - AYA-AYA.AX

Artrya Appoints New CEO, CFO

MT Newswires Live

BRIEF-Artrya Says John Konstantopoulos Appointed As CEO

Artrya Ltd - Bernie Ridgeway to Become Executive Chair

THOMSON REUTERS

Artrya Ltd - John Konstantopoulos Appointed as CEO

THOMSON REUTERS

Artrya Ltd - Harvey Farrington Appointed as Acting CFO

THOMSON REUTERS

ASX ALERT-Artrya Leadership Transition-AYA.AX

Artrya Files With US FDA Pre Market Submission for AI-Based Coronary Plaque Detection Tool

MT Newswires Live

BRIEF-Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque Module

Artrya Ltd - Submits FDA 510(K) Application for Salix Coronary Plaque Module

THOMSON REUTERS

Artrya Obtains 36-Month Contract with Lumus Imaging for Salix Coronary Anatomy Platform; Shares Up 3%

MT Newswires Live

BRIEF-Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary Anatomy

Artrya Ltd - Secures Contract With Lumus Imaging for Use of Salix Coronary Anatomy

THOMSON REUTERS

BUZZ-Australia's Artrya climbs as FDA clears Salix for US sale

BRIEF-Artrya Secures FDA Clearance For Salix Coronary Anatomy

Artrya pops +11% on yet another FDA approval for an Aussie biotech

The Market Herald

Artrya Ltd - Secures FDA Clearance for Salix Coronary Anatomy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AYA.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AYA.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","market":"AU","secType":"STK","nameCN":"ARTRYA LTD","latestPrice":1.125,"timestamp":1752819120000,"preClose":1.02,"halted":0,"volume":529350,"delay":0,"nameEN":"ARTRYA LTD","floatShares":76266672,"shares":113705117,"eps":-0.181711,"marketStatus":"Market Closed","change":0.105,"latestTime":"07-18 16:12:00 AEST","open":1.03,"high":1.175,"low":1.015,"amount":580222,"amplitude":0.156863,"askPrice":1.15,"askSize":49494,"bidPrice":1.11,"bidSize":3220,"shortable":3,"etf":0,"ttmEps":-0.181711,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":1.02,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":1.4818798310852974,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA.AU\",,,,,undefined,":{"symbol":"AYA.AU","floatShares":76266672,"roa":"-43.33%","roe":"-75.75%","lyrEps":-0.178019,"volumeRatio":1.4818798310852974,"shares":113705117,"dividePrice":0,"high":1.175,"amplitude":0.156863,"preClose":1.02,"low":1.015,"week52Low":0.23,"pbRate":"8.71","psRate":"9839.87","week52High":1.175,"institutionHeld":0,"latestPrice":1.125,"committee":-0.877831,"eps":-0.181711,"divideRate":0,"volume":529350,"delay":0,"ttmEps":-0.181711,"open":1.03,"prevYearClose":0.53,"prevWeekClose":0.995,"prevMonthClose":0.72,"prevQuarterClose":0.72,"fiveDayClose":0.995,"twentyDayClose":0.63,"sixtyDayClose":0.61},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AYA.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551903238","title":"Application for quotation of securities - AYA-AYA.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2551903238","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551903238?lang=en_us&edition=fundamental","pubTime":"2025-07-14 15:48","pubTimestamp":1752479336,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250714:nASX7FWvTs","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nASXbRwDCx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2550696281","title":"BUZZ-Australia's Artrya rises to highest since January on US hospital group contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2550696281","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550696281?lang=en_us&edition=fundamental","pubTime":"2025-07-10 11:16","pubTimestamp":1752117376,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Artrya rises to highest since January on US hospital group contract** Shares of Artrya Ltd AYA.AX rise as much as 8.2% to A$0.99, hitting their highest level since January 17** Medical technology firm signs a $0.6 mln, 5-year commercial agreement with Tanner Health, a U.S.-based hospital operator ** Under the contract, AYA's AI cloud platform for coronary artery disease management will be rolled out across Tanner Health's network of hospitals, once cleared by the FDA** Co expects its first U.S. revenue generated from the AI platform in the current quarter ** Stock up 6% currently, bringing YTD gains to 83%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nL4N3T7070:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2550662480","title":"Artrya Signs $600,000 SaaS Deal With US Non-Profit Healthcare Provider","url":"https://stock-news.laohu8.com/highlight/detail?id=2550662480","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550662480?lang=en_us&edition=fundamental","pubTime":"2025-07-10 08:54","pubTimestamp":1752108856,"startTime":"0","endTime":"0","summary":"Artrya  has signed a $600,000 five-year Software-as-a-Service deal with Tanner Health for the rollout of the Salix Coronary Anatomy platform for the latter's centers, hospitals, and physician practices, according to a Thursday filing with the Australian bourse.First revenue of the platform via monthly subscription fees is expected this quarter, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094","BK4137","HCSG"],"gpt_icon":0},{"id":"2548564878","title":"Notification of cessation of securities - AYA-AYA.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548564878","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548564878?lang=en_us&edition=fundamental","pubTime":"2025-07-03 14:54","pubTimestamp":1751525681,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250703:nASX1wPJRf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250703:nASX6G9fxy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2548021012","title":"Artrya Appoints New CEO, CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2548021012","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548021012?lang=en_us&edition=fundamental","pubTime":"2025-07-01 13:46","pubTimestamp":1751348772,"startTime":"0","endTime":"0","summary":"Artrya  has appointed Co-Founder John Konstantopoulos as chief executive officer, Global Commercial Manager Harvey Farrington as acting chief financial officer, and Non-Executive Chair Bernie Ridgeway as executive chair, effective July 1, according to a Tuesday Australian bourse filing.The leadership changes come as the company prepares for the US commercialisation of its Salix AI platform, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2548049614","title":"BRIEF-Artrya Says John Konstantopoulos Appointed As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2548049614","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548049614?lang=en_us&edition=fundamental","pubTime":"2025-07-01 07:54","pubTimestamp":1751327650,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Says John Konstantopoulos Appointed As CEOJuly 1 (Reuters) - Artrya Ltd AYA.AX:JOHN KONSTANTOPOULOS APPOINTED AS CEOHARVEY FARRINGTON APPOINTED AS ACTING CFOBERNIE RIDGEWAY TO BECOME EXECUTIVE CHAIRFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0ZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2548504631","title":"Artrya Ltd - Bernie Ridgeway to Become Executive Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2548504631","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548504631?lang=en_us&edition=fundamental","pubTime":"2025-07-01 07:06","pubTimestamp":1751324776,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0ZG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2548313046","title":"Artrya Ltd - John Konstantopoulos Appointed as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2548313046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548313046?lang=en_us&edition=fundamental","pubTime":"2025-07-01 07:06","pubTimestamp":1751324776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0ZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2548046318","title":"Artrya Ltd - Harvey Farrington Appointed as Acting CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2548046318","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548046318?lang=en_us&edition=fundamental","pubTime":"2025-07-01 07:06","pubTimestamp":1751324776,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nFWN3SX0ZG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2548804645","title":"ASX ALERT-Artrya Leadership Transition-AYA.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2548804645","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548804645?lang=en_us&edition=fundamental","pubTime":"2025-07-01 07:06","pubTimestamp":1751324771,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX2p94QX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX4xl2bt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2544456989","title":"Artrya Files With US FDA Pre Market Submission for AI-Based Coronary Plaque Detection Tool","url":"https://stock-news.laohu8.com/highlight/detail?id=2544456989","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544456989?lang=en_us&edition=fundamental","pubTime":"2025-06-17 07:35","pubTimestamp":1750116919,"startTime":"0","endTime":"0","summary":"Artrya  submitted a 510 application to the US Food and Drug Administration  for its Salix Coronary Plaque module, which enables near real-time, point-of-care detection of coronary plaque, according to a Monday filing with the Australian bourse.The company expects US FDA clearance in the third quarter of the year, the filing said.Upon approval, the module will qualify for reimbursement worth $950 per assessment, the filing added.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2543100196","title":"BRIEF-Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2543100196","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543100196?lang=en_us&edition=fundamental","pubTime":"2025-06-16 09:29","pubTimestamp":1750037353,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Ltd Submits FDA 510(K) Application For Salix Coronary Plaque ModuleJune 16 (Reuters) - Artrya Ltd AYA.AX:SUBMITS FDA 510(K) APPLICATION FOR SALIX CORONARY PLAQUE MODULEFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250616:nFWN3SG0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2543614334","title":"Artrya Ltd - Submits FDA 510(K) Application for Salix Coronary Plaque Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2543614334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543614334?lang=en_us&edition=fundamental","pubTime":"2025-06-16 06:48","pubTimestamp":1750027706,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250615:nFWN3SG0K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2524139269","title":"Artrya Obtains 36-Month Contract with Lumus Imaging for Salix Coronary Anatomy Platform; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2524139269","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524139269?lang=en_us&edition=fundamental","pubTime":"2025-04-01 12:22","pubTimestamp":1743481363,"startTime":"0","endTime":"0","summary":"Artrya  won a 36-month commercial contract with Lumus Imaging for the use of the Salix Coronary Anatomy platform, according to a Tuesday filing with the Australian bourse.Salix is designed to detect critical markers, including high-risk plaque, from CT coronary angiogram scans generated by a photon-counting CT scanner, per the filing.The contract is expected to bring in revenue through a software-as-a-service subscription model, the filing stated.Artrya's shares were up 3% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2524990660","title":"BRIEF-Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524990660","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524990660?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:35","pubTimestamp":1743460536,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Secures Contract With Lumus Imaging For Use Of Salix Coronary AnatomyApril 1 (Reuters) - Artrya Ltd AYA.AX:SECURES CONTRACT WITH LUMUS IMAGING FOR USE OF SALIX CORONARY ANATOMYFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA.AU","BK7094"],"gpt_icon":0},{"id":"2524190667","title":"Artrya Ltd - Secures Contract With Lumus Imaging for Use of Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190667?lang=en_us&edition=fundamental","pubTime":"2025-04-01 06:34","pubTimestamp":1743460468,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE1MF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2522252569","title":"BUZZ-Australia's Artrya climbs as FDA clears Salix for US sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2522252569","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522252569?lang=en_us&edition=fundamental","pubTime":"2025-03-28 10:04","pubTimestamp":1743127491,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Artrya climbs as FDA clears Salix for US sale** Shares of medical technology co Artrya AYA.AX rise 9.4% to A$0.875** Stock hits its highest level since January 20** Co secures U.S. Food and Drug Administration  clearance for commercial sale of Salix Coronary Anatomy in the United States** Salix is the first point of care approach for assessing coronary artery disease, says co** About 1.9 million shares change hands, 9.7 times the 30-day average volume of shares** Stock up 50.9% this year, as of last close  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL6N3QB02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2522563381","title":"BRIEF-Artrya Secures FDA Clearance For Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522563381","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522563381?lang=en_us&edition=fundamental","pubTime":"2025-03-28 09:14","pubTimestamp":1743124485,"startTime":"0","endTime":"0","summary":"BRIEF-Artrya Secures FDA Clearance For Salix Coronary AnatomyMarch 28 (Reuters) - Artrya Ltd AYA.AX:SECURES FDA CLEARANCE FOR SALIX CORONARY ANATOMYFurther company coverage: AYA.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QA1DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","AYA.AU"],"gpt_icon":0},{"id":"2522756550","title":"Artrya pops +11% on yet another FDA approval for an Aussie biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2522756550","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522756550?lang=en_us&edition=fundamental","pubTime":"2025-03-28 08:50","pubTimestamp":1743123000,"startTime":"0","endTime":"0","summary":"Artrya  is the latest Aussie biotech stock to score an FDA approval and consequent rewarding share price jump from traders and investors.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Being approved is Artrya’s coronary imaging software platform ‘Salix’, called Salix Coronary Anatomy  in full. Not to overstate the obvious, but we’re talking about an ‘AI activated’  computer program – not a drug.According to Artrya, Salix is a breakthrough in the assessment of coronary artery disease – the first in 50 years. This statement is hard to fact-check, if it’s checkable at all.Those gains might have already been priced in an FDA approval. But for now, the company is keen to see SCA launch across a series of U.S. hospitals.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and con","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/artrya-pops-11-on-yet-another-fda-approval-for-an-aussie-biotech-2025-03-28/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["SCA","AYA.AU","BK7094"],"gpt_icon":0},{"id":"2522147555","title":"Artrya Ltd - Secures FDA Clearance for Salix Coronary Anatomy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522147555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522147555?lang=en_us&edition=fundamental","pubTime":"2025-03-28 06:39","pubTimestamp":1743115149,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AYA.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AYA.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AYA.AU\",market:\"AU\",,,undefined,":[]}}